Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohort — Àlex G. Segura (2022) | RDL Network
Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohort
Article 2022 en
Authors
ÀS
Àlex G. Segura
AM
Albert Martínez-Pinteño
PG
Patricia Gassó
Abstract
1 min read
Our findings provide new evidence of the effects of metabolic genetic risk on the development of metabolic dysregulation. The future establishment of genetic profiling tools in clinical procedures could enable practitioners to better personalize antipsychotic treatment selection and dosage.
Patricia Gassó, Joan Albert Arnáiz, Sergi Mas, Amàlia Lafuente, Miquel Bioque, Manuel J. Cuesta, Covadonga M. Díaz‐Caneja, Clemente García‐Rizo, António Lobo, Ana González‐Pinto, Mara Parellada, Iluminada Corripio, Eduard Vieta, Josefina Castro‐Fornieles, Anna Mané, Natàlia Rodríguez, Daniel Boloc, Jerónimo Sáiz-Ruiz, Miquel Bernardo
Sergi Mas, Daniel Boloc, Natalia Rodríguez, Gisela Mezquida, Sílvia Amoretti, Manuel J. Cuesta, Javier González‐Peñas, Alicia García-Alcón, António Lobo, Ana González‐Pinto, Iluminada Corripio, Eduard Vieta, Josefina Castro‐Fornieles, Anna Mané, Pilar A. Sáiz, Patricia Gassó, Miquel Bioque, Miquel Bernardo
Oveis Jamialahmadi, Antonio De Vincentis, Federica Tavaglione, Francesco Malvestiti, Ruifang Li‐Gao, Rosellina Margherita Mancina, Marcus Alvarez, Kyla Gelev, Samantha Maurotti, Umberto Vespasiani‐Gentilucci, Frits R. Rosendaal, Julia Kozlitina, Päivi Pajukanta, François Pattou, Luca Valenti, Stefano Romeo
Discussion(0)
No comments yet. Be the first to comment.